Natera Net Income 2014-2023 | NTRA
Natera annual/quarterly net income history and growth rate from 2014 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Natera net income for the quarter ending December 31, 2023 was $-0.078B, a 45.27% decline year-over-year.
- Natera net income for the twelve months ending December 31, 2023 was $-0.435B, a 20.63% decline year-over-year.
- Natera annual net income for 2023 was $-0.435B, a 20.63% decline from 2022.
- Natera annual net income for 2022 was $-0.548B, a 16.13% increase from 2021.
- Natera annual net income for 2021 was $-0.472B, a 105.32% increase from 2020.
| Natera Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-435 |
| 2022 | $-548 |
| 2021 | $-472 |
| 2020 | $-230 |
| 2019 | $-125 |
| 2018 | $-128 |
| 2017 | $-138 |
| 2016 | $-100 |
| 2015 | $-70 |
| 2014 | $-5 |
| 2013 | $-37 |
| Natera Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-78 |
| 2023-09-30 | $-109 |
| 2023-06-30 | $-111 |
| 2023-03-31 | $-137 |
| 2022-12-31 | $-143 |
| 2022-09-30 | $-121 |
| 2022-06-30 | $-145 |
| 2022-03-31 | $-139 |
| 2021-12-31 | $-141 |
| 2021-09-30 | $-151 |
| 2021-06-30 | $-116 |
| 2021-03-31 | $-64 |
| 2020-12-31 | $-76 |
| 2020-09-30 | $-58 |
| 2020-06-30 | $-60 |
| 2020-03-31 | $-35 |
| 2019-12-31 | $-35 |
| 2019-09-30 | $-23 |
| 2019-06-30 | $-32 |
| 2019-03-31 | $-34 |
| 2018-12-31 | $-32 |
| 2018-09-30 | $-30 |
| 2018-06-30 | $-34 |
| 2018-03-31 | $-33 |
| 2017-12-31 | $-47 |
| 2017-09-30 | $-28 |
| 2017-06-30 | $-29 |
| 2017-03-31 | $-33 |
| 2016-12-31 | $-42 |
| 2016-09-30 | $-26 |
| 2016-06-30 | $-23 |
| 2016-03-31 | $-9 |
| 2015-12-31 | $-23 |
| 2015-09-30 | $-18 |
| 2015-06-30 | $-20 |
| 2015-03-31 | $-10 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2014-06-30 | $-1 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.700B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.697B | 15.52 |
| Cencora (COR) | United States | $47.247B | 18.86 |
| ICON (ICLR) | Ireland | $24.578B | 24.24 |
| DiDi Global (DIDIY) | China | $22.930B | 0.00 |
| Avantor (AVTR) | United States | $16.557B | 22.81 |
| CochLear (CHEOY) | $13.675B | 0.00 | |
| Viatris (VTRS) | United States | $13.496B | 3.85 |
| Revvity (RVTY) | United States | $12.448B | 21.67 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.029B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.979B | 21.84 |
| Medpace Holdings (MEDP) | United States | $11.658B | 38.35 |
| Solventum (SOLV) | United States | $10.708B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.966B | 52.04 |
| Bausch + Lomb (BLCO) | Canada | $5.145B | 19.78 |
| Doximity (DOCS) | United States | $4.625B | 34.43 |
| Organon (OGN) | United States | $4.601B | 4.46 |
| PACS (PACS) | United States | $3.460B | 0.00 |
| Progyny (PGNY) | United States | $3.177B | 53.32 |
| Sotera Health (SHC) | United States | $3.139B | 15.40 |
| Surgery Partners (SGRY) | United States | $3.044B | 28.28 |
| Life Times (LTH) | United States | $2.774B | 30.65 |
| GoodRx Holdings (GDRX) | United States | $2.631B | 133.20 |
| Premier (PINC) | United States | $2.522B | 9.23 |
| Teladoc Health (TDOC) | United States | $2.252B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.141B | 6.93 |
| Agilon Health (AGL) | United States | $2.121B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.816B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| Establishment Labs Holdings (ESTA) | $1.325B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.273B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.947B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.759B | 7.85 |
| Embecta (EMBC) | United States | $0.617B | 4.08 |
| InnovAge Holding (INNV) | United States | $0.548B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.518B | 0.00 |
| Enhabit (EHAB) | United States | $0.515B | 46.64 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 0.00 |
| CareDx (CDNA) | United States | $0.423B | 0.00 |
| LifeMD (LFMD) | United States | $0.404B | 0.00 |
| Beauty Health (SKIN) | United States | $0.404B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.395B | 0.00 |
| DocGo (DCGO) | United States | $0.366B | 58.50 |
| MultiPlan (MPLN) | United States | $0.356B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
| ModivCare (MODV) | United States | $0.312B | 4.14 |
| GeneDx Holdings (WGS) | United States | $0.271B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
| Sharecare (SHCR) | United States | $0.250B | 0.00 |
| So-Young (SY) | China | $0.131B | 44.00 |
| Biodesix (BDSX) | United States | $0.125B | 0.00 |
| Oncology Institute (TOI) | United States | $0.084B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |